Biosimilar 與 DRUGDOCS 使用情況與統計

Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics. ** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
  • Apple App Store
  • 付費
  • 醫療

商店排名

- -

DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

Biosimilar與 DRUGDOCS 比較排名

比較過去 28 天的 Biosimilar 排名趨勢與 DRUGDOCS

BiosimilarBiosimilar#132

排名

各國 Biosimilar vs. DRUGDOCS 排名比較

比較過去 28 天的 Biosimilar 排名趨勢與 DRUGDOCS

所有類別

無可用數據

醫療

應用程式
頂級國家
排名
#132
- -
- -

使用我們的免費試用版,與所有網站進行比較

立即開始
Biosimilar VS.
DRUGDOCS

12月 19, 2024